MAPT and Alzheimer disease: Alzheimer's disease (AD) is a chronic, biologically heterogeneous neurodegenerative brain disorder that is neuropathologically characterized by senile plaques composed of amyloid-β (Aβ) peptides as well as neurofibrillary tangles consisting of hyperphosphorylated tau (1).